| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology,*
Tufts University,
Schools of Medicine and Veterinary Medicine, Boston, Massachusetts, the
Department of Biology,
Tufts Unversity,
Medford, Massachusetts, the Department of
Pathology,
Beth Israel Deaconess Medical
Center, West Campus, Harvard Medical School, Boston, Massachusetts, and
the Department of Urology,§
Stanford Medical
Center, Stanford, California
In situ hybridization and immunohistochemistry were used to localize and compare the expression of the long form of the human prolactin receptor in fetal, prepubertal, and adult prostate. Results were then compared with hyperplastic, dysplastic, and neoplastic lesions. Both receptor message and protein were predominately localized in epithelial cells of the fetal, neonatal, prepubertal, and normal adult prostate. In hyperplastic lesions the expression of the receptor was unchanged with respect to normal epithelial cells. Irrespective of grade, markedly enhanced expression of the receptor was evident in dysplastic lesions. In lower Gleason grade carcinomas the intensity of receptor signal at the message and protein levels approximated that found in normal prostatic epithelium. However, in foci within higher grade cancers, receptor expression appeared diminished. Results from our study suggest that prolactin action plays a role in the development and maintenance of the human prostate and may also participate in early neoplastic transformation of the gland. Diminution of receptor expression in high grade neoplasms could reflect the emergence of a population of cells that are no longer responsive to the peptide hormone.
This article has been cited by other articles:
 |
|
 |
|
  S. N. Lauber and N. J. Gooderham The Cooked Meat Derived Genotoxic Carcinogen 2-Amino-3-Methylimidazo[4,5-b]Pyridine Has Potent Hormone-Like Activity: Mechanistic Support for a Role in Breast Cancer Cancer Res., October 1, 2007; 67(19): 9597 - 9602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Goffin, S. Bernichtein, P. Touraine, and P. A. Kelly Development and Potential Clinical Uses of Human Prolactin Receptor Antagonists Endocr. Rev., May 1, 2005; 26(3): 400 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Berteaux, S Lottin, E Adriaenssens, F Van Coppenolle, X Leroy, J Coll, T Dugimont, and J-J Curgy Hormonal regulation of H19 gene expression in prostate epithelial cells J. Endocrinol., October 1, 2004; 183(1): 69 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, T. J. Ahonen, K. Alanen, J. Xie, M. J. LeBaron, T. G. Pretlow, E. L. Ealley, Y. Zhang, M. Nurmi, B. Singh, et al. Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade Cancer Res., July 15, 2004; 64(14): 4774 - 4782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Robertson, J. Harris, M. J. Naylor, S. R. Oakes, J. Kindblom, K. Dillner, H. Wennbo, J. Tornell, P. A. Kelly, J. Green, et al. Prostate Development and Carcinogenesis in Prolactin Receptor Knockout Mice Endocrinology, July 1, 2003; 144(7): 3196 - 3205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Harkonen Paracrine Prolactin May Cause Prostatic Problems Endocrinology, June 1, 2003; 144(6): 2266 - 2268. [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, W. Luo, D.-T. Chen, K. Earley, J. Tunstead, L.-Y. Yu-Lee, and S.-H. Lin Antitumor Activity of the 16-kDa Prolactin Fragment in Prostate Cancer Cancer Res., January 15, 2003; 63(2): 386 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Feldman, C. Longcope, C. A. Derby, C. B. Johannes, A. B. Araujo, A. D. Coviello, W. J. Bremner, and J. B. McKinlay Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 589 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-Y. Yu-Lee Prolactin Modulation of Immune and Inflammatory Responses Recent Prog. Horm. Res., January 1, 2002; 57(1): 435 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Ahonen, P. L. Harkonen, H. Rui, and M. T. Nevalainen PRL Signal Transduction in the Epithelial Compartment of Rat Prostate Maintained as Long-Term Organ Cultures in Vitro Endocrinology, January 1, 2002; 143(1): 228 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Untergasser, H. Rumpold, E. Plas, M. Witkowski, and P. Berger Seminal Plasma Factors Induce in Vitro PRL Secretion in Smooth Muscle Cells of the Human Prostate J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5577 - 5584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Taplin and S.-M. Ho The Endocrinology of Prostate Cancer J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3467 - 3477. [Full Text] [PDF]
|
|
|
|
|
|
S. J. McPherson, H. Wang, M. E. Jones, J. Pedersen, T. P. Iismaa, N. Wreford, E. R. Simpson, and G. P. Risbridger Elevated Androgens and Prolactin in Aromatase-Deficient Mice Cause Enlargement, But Not Malignancy, of the Prostate Gland Endocrinology, June 1, 2001; 142(6): 2458 - 2467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Kline, H. Roehrs, and C. V. Clevenger Functional Characterization of the Intermediate Isoform of the Human Prolactin Receptor J. Biol. Chem., December 10, 1999; 274(50): 35461 - 35468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Stoker, C. L. Robinette, B. H. Britt, S. C. Laws, and R. L. Cooper Prepubertal Exposure to Compounds That Increase Prolactin Secretion in the Male Rat: Effects on the Adult Prostate Biol Reprod, December 1, 1999; 61(6): 1636 - 1643. [Abstract] [Full Text]
|
|
|
|
|
|
J. B. Kline and C. V. Clevenger Identification and Characterization of the Prolactin-binding Protein in Human Serum and Milk J. Biol. Chem., June 29, 2001; 276(27): 24760 - 24766. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
